Archive · 19 Jun 2025
India's NIV Develops Vaccines for Dengue, Nipah, and More
Scientists in India are working hard to create vaccines for dangerous viruses like dengue, Nipah, and others.
They have a new supercomputer called 'Nakshatra' that helps them quickly study viruses and find out how they change.
They hope to have their own safe and effective dengue vaccine soon.
This will help India protect itself from future health problems.
NIV Pune is developing vaccines and diagnostic tools for multiple viruses.
India's first indigenous dengue vaccine is in the final phase of human trials.
Vaccines are also in development for Kyasanur Forest Disease (KFD), Chandipura, and Nipah viruses.
The 'Nakshatra' supercomputer at NIV Pune can analyze virus sequences rapidly.
The advancements aim to increase India’s self-reliance in handling biological threats.
- Who
- National Institute of Virology (NIV) Pune.
- What
- Development of vaccines and diagnostic tools for several viruses, including dengue, Nipah, and others.
- When
- Ongoing research and development.
- Where
- National Institute of Virology (NIV) Pune, India.
- Why
- To reduce reliance on imported technology and improve epidemic preparedness, also speed up vaccine development and national response.
- Organization
- National Institute of Virology (NIV)
- Location
- Pune, India
- Focus
- Vaccine and diagnostic tool development
- Supercomputer
- Nakshatra
- Dengue Vaccine Status
- Final phase of trials
